Top Markets
#1 EXOD EXOD +22.08%
#2 Ontology Gas Ontology Gas +19.69%
#3 Status Status +14.56%
#4 Fake World Assets Fake World Assets +11.65%
#5 Derive Derive +10.56%
#6 aelf aelf +10.13%
#7 Gas Gas +6.52%
#8 ETHGas ETHGas +6.08%
#9 Anvil Anvil +5.80%
#10 Tornado Cash Tornado Cash +5.60%
Coin of the day
EXOD EXOD
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Mendus AB (publ) Mendus AB (publ)

Mendus AB (publ)

IMMU
Rang in aandelen #25837
Mendus AB (publ), a biopharmaceutical entity formerly known as Immunicum AB... Mendus AB (publ), a biopharmaceutical entity formerly known as Immunicum AB (publ) until its name change in June 2022, specializes in developing immunotherapies and vaccines designed to prevent cancer recurrence. Its primary investigational compound, ilixadencel, is currently progressing through a Phase II MERECA clinical study for kidney cancer, alongside Phase I/II trials targeting liver cancer and gastrointestinal stromal tumors. Additionally, the company is advancing DCP-001, which is undergoing Phase II ADVANCE-II clinical research for acute myeloid leukemia and Phase I/II ALISON trials for ovarian cancers. Mendus maintains research partnerships with PCI Biotech Holding ASA to explore novel cancer vaccination approaches and with the Icahn School of Medicine at Mount Sinai. Founded in 2002, Mendus AB is headquartered in Stockholm, Sweden.
Aandeelprijs
$0.74834668
Laatst gesynchroniseerd: 2026-08-20
Marktkapitalisatie
$45.86M
Verandering (1 dag)
-0.15%
Verandering (1 jaar)
-2.71%
Land
SE
Handel Mendus AB (publ) (IMMU)

Categorie

Healthcare
Aandelsplitsingen voor Mendus AB (publ) (IMMU)
Het aandeel Mendus AB (publ) (symbool: IMMU) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 21, 2026.
Eén aandeel IMMU dat vóór Aug 21, 2026 werd gekocht, staat nu gelijk aan 0 aandelen IMMU.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US